News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
166 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (22261)
Month
January (3098)
February (3516)
March (3513)
April (3269)
May (4089)
June (3205)
July (2932)
August (3176)
September (2859)
October (3385)
November (3129)
December (2245)
Day
1 (166)
2 (150)
5 (178)
6 (226)
7 (210)
8 (247)
9 (209)
12 (216)
13 (177)
14 (155)
15 (161)
16 (92)
19 (125)
20 (129)
21 (97)
26 (129)
27 (119)
28 (112)
29 (137)
30 (94)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
26
27
28
29
30
Business
Watson Pharmaceuticals, Inc. Third Quarter 2012 Non-GAAP Diluted EPS Increases 24% to $1.35; Net Revenue Increases 19% to $1.29 Billion
November 1, 2012
·
1 min read
Business
Solta Medical, Inc. Reports Third Quarter Results
November 1, 2012
·
1 min read
Pharm Country
Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012
November 1, 2012
·
3 min read
Drug Development
Omeros Corporation Announces Enrollment in Phase 1 Clinical Trial Evaluating OMS824
November 1, 2012
·
3 min read
AEterna Zentaris to Present Proof of Concept for Disorazol Z Cytotoxic Conjugates Such as AEZS-125 in Ovarian Cancer Mouse Model at Upcoming ENA Symposium
November 1, 2012
·
1 min read
Biotech Bay
Amarantus BioSciences, Inc. Explores Orphan Drug Strategy Based on MANF Protein Folding
November 1, 2012
·
4 min read
Business
Rubicon Genomics, Inc. Partners With Diagenode, Inc. to Increase Efficiency and Speed of ChIP Sample Preparation for Next Generation Sequencing
November 1, 2012
·
4 min read
Biotech Bay
AcelRx Pharmaceuticals to Hold Third Quarter 2012 Financial Results Conference Call and Webcast on November 6, 2012
November 1, 2012
·
3 min read
Business
Michael Lehmann Appointed Patheon Inc.'s President of Global Pharmaceutical Development Services
November 1, 2012
·
2 min read
Deals
Neovasc Inc. Finalizes US $4.6 Million Agreement Giving LeMaitre Vascular, Inc. Rights to In-House Manufacture of Xenosure® Surgical Patch
November 1, 2012
·
4 min read
Previous
9 of 17
Next